DURVAXITY
LIVE

Serial Number

97347180

Owner

Seqirus Inc.

Attorney

Nancy Sabarra

Filing Date

Apr 5, 2022

Add to watchlist:

No watchlists yet
View on USPTO

DURVAXITY Trademark

Serial Number: 97347180

DURVAXITY is a trademark filed by Seqirus Inc. on April 5, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Seqirus Inc. (84 trademarks)

475 Green Oaks Parkway
Holly Springs, NC 27540

Entity Type: 03

Trademark Details

Filing Date

April 5, 2022

Registration Date

Not Registered

Published for Opposition

March 21, 2023

Goods & Services

Active chemical and biological ingredients for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) encapsulated in lipid nanoparticles for preventing and treating viruses and respiratory disorders; Biochemical preparations for in vivo, ex vivo, on vivo, and in vitro scientific research and medical research; Biochemicals for use in the manufacture of pharmaceuticals for preventing and treating viruses and respiratory disorders; Lipid nanoparticles for scientific, laboratory or medical research use

Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines

Vaccine adjuvants; Drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of a wide range of pharmaceuticals

Medical services; medical information; providing a website featuring medical information

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 21, 2025 EXRA
SOU EXTENSION 5 GRANTED
Nov 20, 2025 EX5G
SOU TEAS EXTENSION RECEIVED
Nov 17, 2025 EEXT
SOU EXTENSION 5 FILED
Nov 16, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 26, 2025 EXRA
SOU EXTENSION 4 GRANTED
Apr 25, 2025 EX4G
SOU EXTENSION 4 FILED
Apr 25, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 25, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 11, 2024 EXRA
SOU EXTENSION 3 GRANTED
Dec 11, 2024 EX3G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 9, 2024 AITU
SOU EXTENSION 3 FILED
Nov 12, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Nov 12, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 9, 2024 EXRA
SOU EXTENSION 2 GRANTED
May 8, 2024 EX2G
SOU EXTENSION 2 FILED
May 8, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
May 8, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 16, 2023 EXRA
SOU EXTENSION 1 GRANTED
Nov 14, 2023 EX1G
SOU EXTENSION 1 FILED
Nov 14, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 14, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 16, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 21, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 21, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 1, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 15, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Feb 13, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 19, 2023 GNFN
FINAL REFUSAL E-MAILED
Jan 19, 2023 GNFR
FINAL REFUSAL WRITTEN
Jan 19, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 10, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 10, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 10, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 31, 2022 GNRN
NON-FINAL ACTION E-MAILED
May 31, 2022 GNRT
NON-FINAL ACTION WRITTEN
May 31, 2022 CNRT
ASSIGNED TO EXAMINER
May 23, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 11, 2022 NWOS
NEW APPLICATION ENTERED
Apr 8, 2022 NWAP